你好,欢迎访问上海交通大学附属第一人民医院公济文库!
所在位置: 首页 - 科室团队导航 - 肿瘤临床医学中心
相关导航
按语种分组
  • 任何
  • 413 中文
  • 372 外文
年代
  • 任何
  • 49 2021
  • 90 2020
  • 60 2019
  • 63 2018
  • 58 2017
  • 45 2016
  • 35 2015
  • 34 2014
  • 18 2013
  • 22 2012
  • 34 2011
  • 18 2010
  • 214 2000-2009
  • 41 1990-1999
按类型分组
  • 任何
  • 366 中文期刊
  • 362 外文期刊
  • 27 中文会议论文
  • 18 中文专利
  • 9 外文专利
  • 更多
按重要期刊分组
  • 任何
  • 315 SCI科学引文索引(美)
  • 261 国内统计源期刊
  • 250 SCIE
  • 213 CSCD中国科学引文库
  • 181 CA化学文摘(美)
  • 更多
按来源刊物分组
  • 任何
  • 23 中国癌症杂志
  • 17 肿瘤
  • 16 中华眼科杂志
  • 13 现代生物医学进展
  • 12 Annals of Onc
  • 更多
科室简介: 成果数量:785

上海交通大学附属第一人民医院肿瘤科是上海市三甲综合医院中最早设立的肿瘤专科,是医院“十二五”期间重点发展的学科之一。2009年,医院整合肿瘤相关学科资源,成立了肿瘤中心,学科带头人黄倩教授,中心主任王理伟教授,肿瘤中心副主任王红霞(兼肿瘤科副主任[主持,南])、刘勇副主任医师,北部执行主任李琦主任医... [详细]

本科室知名学者:
本科室科研趋势: 发文数量 期刊收录
条数据
导出

作者: Wang, Z.;Xue, X.;Lu, H.;He, Y.;Lu, Z.;Chen, Z.;Yuan, Y.;Tang, N.;Dreyer, C.A.;Quigley, L.;Curro, N.;Lam, K.S.;Walton, J.H.;Lin, T.-Y.;Louie, A.Y.;Gilbert, D.A.;Liu, K.;Ferrara, K.W.;Li, Y. (a Department of Radiology, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China; b Department of Biochemistry and Molecular Medicine, UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, CA, United States; c Department of Radiology, First Affiliated Hospital of Soochow University, Suzhou, China; d Department of Physics, University of California, Davis, CA, United States; e Department of Physics, Georgetown University, Washington, DC, United States; f Department of Materials Science and Engineering, University of Tennessee, Knoxville, TS, United States; g Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis, Sacramento, CA, United States; h UC Davis NMR Facility, Davis, CA, United States; i Department of Biomedical Engineering, University of California Davis, Davis, CA, United States; j Department of Radiology, Stanford University, Palo Alto, CA, United States)

出处: Nature Nanotechnology 2020 Vol.15 No.6 P482-490

摘要: Distance-dependent magnetic resonance tuning (MRET) technology enables the sensing and quantitative imaging of biological targets in vivo, with the ad ...

作者: Xu, S.;Moss, T.J.;Laura Rubin, M.;Ning, J.;Eterovic, K.;Yu, H.;Jia, R.;Fan, X.;Tetzlaff, M.T.;Esmaeli, B. (a Orbital Oncology & Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1488, Houston, TX 77030, United States; b Department of Ophthalmology, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; c Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States; d Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States; e Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States; f Pathology Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; g Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States; h Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States)

出处: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 Vol.33 No.7 P1256-1263

摘要: Ocular adnexal sebaceous carcinoma (OASeC) is an aggressive eyelid carcinoma. Analysis of molecular-genetic drivers of this disease could reveal new p ...

作者: Libin Song, Zhixiao Fang, Chuanfang Pan, Xiangyuan Chen, Xiang Qian, Yunyun Cai, Xiumei Zhang, Luming Liu (Affiliations 1 Department of Integrative Oncology, Fudan University, Shanghai Cancer Center, Shanghai, China. 2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. 3 Institute of Translational Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 4 Department of Oncology, Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China. 5 Department of Geriatrics, Huadong Hospital, Shanghai Medical College, Fudan University, Shanghai, China. 6 Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Zheijang, China. 7 Department of Traditional Chinese Medicine, Zhejiang Cancer Hospitall, Zheijang, China. 8 Department of Integrated Traditional Western Medicine, Minhang Branch of Fudan University of Shanghai Cancer Center, Shanghai, China.)

出处: Frontiers in oncology 2020 Vol.10 P584330

关键词: Babao Dan;enrichment analysis;metabolism;pancreatic cancer;transcriptome.

摘要: Background and aims: Pancreatic ductal adenocarcinoma (PDAC) is one of refractory malignancies without efficient therapeutics. Babao Dan (BBD) was par ...

作者: Xinjian Liu, Xuhui Bao, Mengjie Hu, Hanman Chang, Meng Jiao, Jin Cheng, Liyi Xie, Qian Huang, Fang Li, Chuan-Yuan Li (Affiliations 1 Department of Dermatology, Duke University Medical Center, Durham, NC, USA. 2 Department of Biochemistry, Molecular Cancer Research Center, School of Medicine, Sun Yat-sen University, Shenzhen, Guangdong, China. 3 Molecular Diagnostic Laboratory of Cancer Center, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. 4 Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. 5 Department of Dermatology, Duke University Medical Center, Durham, NC, USA. Chuan.Li@duke.edu. 6 Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, USA. Chuan.Li@duke.edu. 7 Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. Chuan.Li@duke.edu.)

出处: Nature 2020

摘要: Despite its success in achieving the long-term survival of 10-30% of treated individuals, immune therapy is still ineffective for most patients with c ...

作者: Xing-Wen Fan MD;Yu Yang MD;Hong-Bing Wang MD;Yin Xu MD;Mei Kang MD;Li-Yi Xie MD, PhD;Ling Li MD, PhD;Wen-Tao Fang MD, PhD;Kuai-Le Zhao MD, PhD;Hai-Quan Chen MD, PhD;Jia-Qing Xiang MD;Yee C. Ung MD;C. Shun Wong MD;Guo-Liang Jiang MD, PhD;Kai-Liang Wu MD, PhD (2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China 1 Department of Radiation Oncology, Shanghai Cancer Center, Fudan University, Shanghai 200032, China 4 Department of Thoracic Surgery, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University 200030, China 3 Clinical Research Center, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University 200080, Shanghai, China 6 Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto ON M4N3M5, Canada 5 Department of Thoracic Surgery, Shanghai Cancer Center, Fudan University, Shanghai 200032, China 7 Department of Radiation Oncology, Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai Proton and Heavy Ion Center, Shanghai 201315, Chin)

出处: International Journal of Radiation Oncology*Biology*Physics 2020

关键词: thymoma;thymic carcinoma;intensity-modulated radiotherapy;etoposide/cisplatin

摘要: Introduction This prospective phase II study evaluated the efficacy and safety of intensity-modulated radiotherapy (IMRT) plus etoposide/cisplatin (E ...

作者: Wen, Shihong (AUTHOR);Li, Xiang (AUTHOR);Ling, Yihong (AUTHOR);Chen, Shaoqian (AUTHOR);Deng, Qiwen (AUTHOR);Yang, Lu (AUTHOR);Li, Ying (AUTHOR);Shen, Jiantong (AUTHOR);Qiu, Yuxin (AUTHOR);Zhan, Yaqing (AUTHOR);Lai, Hanjin (AUTHOR);Zhang, Xuyu (AUTHOR);Ke, Zunfu (AUTHOR)( kezunfu@mail.sysu.edu.cn);Huang, Wenqi (AUTHOR)( scorpiosslove@aliyun.com) (1 Department of Anesthesiology, The First Affiliated Hospital, Sun Yat‐sen University, Guangzhou, China 2 Department of Anesthesiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China 3 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat‐sen University Cancer Center, Guangzhou, China 4 Department of Pathology, Sun Yat‐sen University Cancer Center, Guangzhou, China 5 Department of Medical Laboratory, The First Affiliated Hospital, Sun Yat‐sen University, Guangzhou, China 6 State Key Laboratory of Applied Microbiology Southern China, Guangzhou, China 7 Guangdong Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou, China 8 Surgical Intensive Care Unit, The First Affiliated Hospital, Sun Yat‐sen University, Guangzhou, China 9 Department of Pathology, The First Affiliated Hospital, Sun Yat‐sen University, Guangzhou, China)

出处: FASEB Journal 2020 Vol.34 No.3 P4384-4402

关键词: cell death;gut‐liver axis;high‐mobility group box‐1;inflammation

摘要: Reperfusion of the ischemic intestine often leads to drive distant organ injury, especially injuries associated with hepatocellular dysfunction. The p ...

作者: Qingying Wang, Qinyi Zhang, Qingxian Li, Jing Zhang, Jiawen Zhang (Affiliations 1 Department of Obstetrics and Gynecology, Shanghai Tenth People\'s Hospital, School of Medicine, Tongji University, Shanghai, China. 2 Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China. 3 Department of Gynecology and Obstetrics, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. 4 Department of Integrated Therapy, Shanghai Cancer Center, Fudan University, Shanghai, China. 5 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.)

出处: Molecular genetics & genomic medicine 2020 Pe1547

关键词: immune infiltration;m6A regulators;ovarian cancer;survival.

摘要: Background: N 6 -methyladenosine (m 6 A) modification is one of the critical gene regulatory mechanisms implicated in cancer biology. However, the r ...

作者: Xiao Gao, Qingwei Wang, Ying Wang, Jiang Liu, Shuang Liu, Jian Liu, Xingli Zhou, Li Zhou, Hui Chen, Linian Pan, Jiwei Chen, Da Wang, Qing Zhang, Shihui Shen, Yu Xiao, Zhipeng Wu, Yiyun Cheng, Geng Chen, Syeda Kubra, Jun Qin, Lan Huang, Pei Zhang, Chuangui Wang, Robb E Moses, David M Lonard, Bert W O\' Malley, Fuad Fares, Bianhong Zhang, Xiaotao Li, Lei Li, Jianru Xiao (Affiliations 1 East China Normal University and Shanghai Changzheng Hospital Joint Research Center for Orthopedic Oncology, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China. 2 Department of Orthopedic Oncology, Changzheng Hospital, The Second Military Medical University, 415 Fengyang Road, Shanghai, 200003, China. 3 Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China. 4 Department of Surgery, Department of Physiology & Cell Biology, College of Medicine, Davis Heart and Lung Research Institute, Wexner Medical Center, The Ohio State University, Columbus, OH, 43210, USA. 5 The Institute of Aging Research, School of Medicine, Hangzhou Normal University, Hangzhou, 310036, Zhejiang, China. 6 Department of Hematology, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China. 7 Reproductive & Developmental Biology Laboratory, National Institute of Environmental Health Sciences (NIEHS), Research Triangle Park, NC, 27709, USA. 8 The Joint Laboratory of Translational Medicine, National Center for Protein Sciences (Beijing) and Peking University Cancer Hospital, State Key Laboratory of Proteomics, Institute of Lifeomics, 102206, Beijing, China. 9 Department of Physiology and Biophysics, University of California, Irvine, CA, 92697, USA. 10 Department of Pathology, The Second Chengdu Municipal Hospital, Chengdu, 610017, China. 11 Institute of Translational Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 12 Department of Molecular and Cellular Biology, Dan L. Duncan Cancer Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX, 77030, USA. 13 Department of Human Biology. Faculty of Natural Sciences, University of Haifa, Haifa, 3498838, Israel. 14 Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China. zhkyzhbh.549803@163.com. 15 East China Normal University and Shanghai Changzheng Hospital Joint Research Center for Orthopedic Oncology, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China. xiaotaol@bcm.edu. 16 Department of Molecular and Cellular Biology, Dan L. Duncan Cancer Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX, 77030, USA. xiaotaol@bcm.edu. 17 Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China. lllkzj@163.com. 18 East China Normal University and Shanghai Changzheng Hospital Joint Research Center for Orthopedic Oncology, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, China. jianruxiao83@163.com. 19 Department of Orthopedic Oncology, Changzheng Hospital, The Second Military Medical University, 415 Fengyang Road, Shanghai, 200003, China. jianruxiao83@163.com.)

出处: Nature communications 2020 Vol.11 No.1 P4888

摘要: An amendment to this paper has been published and can be accessed via a link at the top of the paper.

作者: Jiawen,Zhang ;Qinyi,Zhang ;Cong,Sun ;Yanjuan,Huang ;Jing,Zhang ;Qingying,Wang (Department of Obstetrics and Gynecology \'(1)\' ; Shanghai Tenth People\'s Hospital [2] ; School of Medicine [3] ; Tongji University [4] ; Shanghai [5] ; China. [6] ; Shanghai General Hospital [7] ; Shanghai Jiaotong University [8] ; First Hospital of Zibo [9] ; Shandong [10] ; School of Pharmacy [11] ; Shanghai University of Medicine and Health Sciences [12] ; Department of Integrated Therapy [13] ; Shanghai Cancer Center [14] ; Fudan University [15] ; China; Department of Oncology [16] ; Shanghai Medical College [17] ; China. Electronic address: crystalzhang12@163.com. [18] ; China. Electronic address: wangqingying@tongji.edu.cn. [19])

出处: Biomedecine & pharmacotherapie 2020 Vol.125 P110000

关键词: ARF/ARL family;ARL4C;Endometrial cancer;Metformin;Prognosis

摘要: Members of ADP-ribosylation factor (ARF)/ARF-like protein (ARL) family regulate malignant phenotype of cancer cells. The present study aims to investi ...

作者: James L,Mulshine ;Ricardo S,Avila ;Ed,Conley ;Anand,Devaraj ;Laurie Fenton,Ambrose ;Tanya,Flanagan ;Claudia I,Henschke ;Fred R,Hirsch ;Robert,Janz ;Ryutaro,Kakinuma ;Stephen,Lam ;Annette,McWilliams ;Peter M A,Van Ooijen ;Matthijs,Oudkerk ;Ugo,Pastorino ;Anthony,Reeves ;Patrick,Rogalla ;Heidi,Schmidt ;Daniel C,Sullivan ;Haije H J,Wind ;Ning,Wu ;Murry,Wynes ;Xie,Xueqian ;David F,Yankelevitz ;John K,Field (Rush University, Chicago, IL. \'(1)\' ; Accumetra, LLC, Clifton Park, NY. [2] ; University of Liverpool, Liverpool, United Kingdom. [3] ; University College, London, United Kingdom. [4] ; GO2 Foundation, Washington, DC. [5] ; Partnership Against Cancer, Toronto, Ontario, Canada. [6] ; Icahn School of Medicine at Mount Sinai, New York, NY. [7] ; Mount Sinai Health System, New York, NY. [8] ; University of Groningen, Groningen, Netherlands. [9] ; National Cancer Center Hospital, Tokyo, Japan. [10] ; University of British Columbia, Vancouver, British Columbia, Canada. [11] ; Fiona Stanley Hospital, Western Australia. [12] ; University Medical College, Groningen, Netherlands. [13] ; Instituti Tumori, Milan, Italy. [14] ; Cornell University, Ithaca, New York, NY. [15] ; Toronto Joint Department of Medical Imaging, University of Toronto, Ontario, Canada. [16] ; Duke University Medical Center, Durham, NC. [17] ; National Cancer Center, Peking Union Medical College, Beijing, China. [18] ; International Association for the Study of Lung Cancer, Denver, CO. [19] ; Shanghai General Hospital, Shanghai, China. [20])

出处: JCO clinical cancer informatics 2020 Vol.4 P89-99

关键词: JAG1.

摘要: To improve outcomes for lung cancer through low-dose computed tomography (LDCT) early lung cancer detection. The International Association for the Stu ...

肿瘤临床医学中心简介

上海交通大学附属第一人民医院肿瘤科是上海市三甲综合医院中最早设立的肿瘤专科,是医院“十二五”期间重点发展的学科之一。2009年,医院整合肿瘤相关学科资源,成立了肿瘤中心,学科带头人黄倩教授,中心主任王理伟教授,肿瘤中心副主任王红霞(兼肿瘤科副主任[主持,南])、刘勇副主任医师,北部执行主任李琦主任医师。目前,肿瘤中心下设肿瘤内科、肿瘤放疗科、肿瘤介入科、肿瘤基因诊断及生物治疗科。目前肿瘤中心核定床位数185张,科室现有医技人员共50人,其中医生36人,正高级职称7人,副高级职称9人,中级职称18人,具有博士学历11人,硕士学历18人,博士研究生导师3人,硕士研究生导师5人;5人曾在国外进修学习,2人目前正在国外学习。肿瘤中心现为中国抗癌协会临床肿瘤学会(CSCO)执行委员会单位,CSCO胰腺癌专家委员会主任委员单位、CSCO抗肿瘤药物安全管理委员会委员单位、上海市抗癌协会理事单位、上海市医学会肿瘤专科委员会副主任委员单位、上海市肿瘤放射治疗专业委员会委员单位、上海市肿瘤化疗质控中心专家委员单位、上海市肿瘤放疗质控专家委员会单位。
2013年,经全院肿瘤相关专科共同努力,肿瘤中心入选国家临床重点专科建设项目,建设经费500万元。近3年,获得国家级课题(含国家自然科学基金重大研究计划、国家“973”“863”计划、重大国际合作)17项(仅2015年获得国家自然科学基金9项)、市级课题10项,各类科研经费2500余万元。在《Nature Medicine》、《Gastroenterology》等杂志发表高质量SCI论文。在胰腺癌的基础研究与临床诊治方面在上海市乃至全国颇具影响,主持编写了《胰腺癌患者健康教育手册》、中国首部《胰腺癌综合诊治中国专家共识》,为上海市胰腺疾病重点实验室及上海交通大学胰腺癌诊治中心。在人才培养方面,1人入选国家杰出青年基金计划、1人入选“百千万人才工程”国家级人选、1人入选上海市医学领军人才、1人入选上海市优秀学科带头人计划、3人入选上海市“浦江人才计划”。
2013年成立了肿瘤诊治中心以来,肿瘤学科得到迅猛发展。中心集肿瘤预防、诊断、综合治疗和康复为一体,能开展各项专科项目并形成如下医疗特色:
1.肿瘤个体化化疗、靶向治疗、免疫治疗:根据每位患者独特的基因表达情况,制定个体化的化疗方案,联合靶向治疗,极大提高了结直肠癌、肺癌、乳腺癌、胃癌等治疗效果。
2.精准放疗:目前拥有直线加速器3台,其中包括最先进的VARIAN-RapidArc治疗系统,实现了对实体肿瘤的精准放疗。现已开展三维适形放射治疗、调强适形放射治疗、图像引导下的三维适形调强放疗、同步放化疗、PET-CT引导下放疗、立体定向放射治疗等。
3.肿瘤微创治疗:在上海市开展了首例纳米刀治疗局部晚期胰腺癌,还包括高强度超声聚焦治疗系统(HIFU刀)、射频/微波肿瘤消融治疗系统、高频热疗系统、放射性粒子组织间植入治疗系统、氩氦刀低温冷冻肿瘤治疗系统、血管介入等技术,适用于治疗肝癌、肺癌等实体肿瘤。
4.肿瘤分子诊断:包括免疫功能检测、EGFR、K-ras、BRAF等基因突变检测,Her-2基因扩增检测,循环血肿瘤细胞检测等,为肿瘤患者个体化治疗与靶向治疗选择,以及预后判断,提供了更准确的方法。
5.开设肿瘤多学科联合诊治:多学科、多专家共同参与,为患者制定个体化、综合治疗方案,实现对每位肿瘤患者的全称管理,为肿瘤患者提供最科学的诊断治疗技术和最优质的一站式服务。
6.肿瘤生物治疗:全国率先开展生物免疫治疗与现有传统治疗手段(化疗、放疗)综合治疗实体肿瘤(胰腺癌、乳腺癌等),开展单病种肿瘤生物免疫治疗临床研究多项,通过规范病例入组,规范细胞制备与使用,规范疗效评价,并建立相应的疗效评估体系及规范。
7.新药临床研究:在医院药物临床研究机构的监督下,牵头、参与国际多中心临床研究,为结直肠癌、胰腺癌、乳腺癌、胃癌、肺癌等患者提供最新的药物治疗。
8.中心静脉置管及护理: 1999年我科成功置入上海市第一根PICC导管,开创了护士进 行中心静脉置管的新篇章。2006年引入PORT技术,2007年在全国率先开展非超声引导下塞丁格(MST)穿刺技术,2009年引入B超引导下置管技术,新技术的引进提高了PICC置管成功率,解决了临床实际问题。
目前,肿瘤中心的主要研究方向有:胰腺癌的临床及基础研究、胰腺癌炎-癌转化的基础研究、乳腺癌的基础与临床转化研究、三阴性乳腺癌的精准与免疫治疗研究、肿瘤放疗后再增殖研究、肺癌基础研究、转录因子对肝癌发生发展影响的机制研究、基因多态性与化疗敏感性的临床研究、血药浓度检测与化疗敏感性的临床研究等。"